Michael L. Sr. Blute
#127,908
Most Influential Person Now
Michael L. Sr. Blute's AcademicInfluence.com Rankings
Michael L. Sr. Blutephilosophy Degrees
Philosophy
#6072
World Rank
#9043
Historical Rank
Logic
#3266
World Rank
#4396
Historical Rank
Michael L. Sr. Blutebiology Degrees
Biology
#8224
World Rank
#11267
Historical Rank
Molecular Biology
#1027
World Rank
#1051
Historical Rank
Download Badge
Philosophy Biology
Michael L. Sr. Blute's Degrees
- Doctorate Medicine Harvard University
Why Is Michael L. Sr. Blute Influential?
(Suggest an Edit or Addition)Michael L. Sr. Blute's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive molecular characterization of clear cell renal cell carcinoma (2013) (1724)
- Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. (2007) (1164)
- An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. (2002) (1062)
- Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma (2003) (1026)
- Solid renal tumors: an analysis of pathological features related to tumor size. (2003) (1004)
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (2016) (931)
- Classification of renal cell carcinoma (1997) (843)
- Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (2006) (843)
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma (2003) (683)
- Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (2008) (672)
- Every minute counts when the renal hilum is clamped during partial nephrectomy. (2010) (631)
- Evidence for a prostate cancer susceptibility locus on the X chromosome. (1998) (620)
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (2004) (613)
- Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. (2004) (592)
- PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma (2007) (530)
- The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus (2004) (465)
- Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome (2005) (447)
- Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. (2004) (404)
- Risk of prostate carcinoma death in patients with lymph node metastasis (2001) (350)
- Survival after complete surgical resection of multiple metastases from renal cell carcinoma (2011) (347)
- Pelvic lymph node dissection in prostate cancer. (2009) (344)
- Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. (2010) (344)
- Comparison of screening methods in the detection of bladder cancer. (1999) (340)
- Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. (2012) (305)
- Mutations in CHEK2 associated with prostate cancer risk. (2003) (299)
- The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. (2007) (298)
- Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. (2007) (289)
- B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival (2006) (288)
- Sunitinib in patients with metastatic renal cell carcinoma (2006) (278)
- Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (277)
- Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot‐assisted techniques (2009) (276)
- Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy (2006) (269)
- Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. (2011) (264)
- Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer (2011) (258)
- Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. (2008) (254)
- Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. (2003) (254)
- Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness (2005) (253)
- B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. (2007) (240)
- The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. (2003) (237)
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma (2008) (235)
- Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. (2008) (233)
- Evidence for autosomal dominant inheritance of prostate cancer. (1998) (233)
- Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. (2009) (221)
- Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery (1996) (220)
- Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. (2005) (213)
- A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. (2005) (207)
- Defining a standard set of patient-centered outcomes for men with localized prostate cancer. (2014) (195)
- Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. (2005) (192)
- Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma (2007) (191)
- Long-term complications of conduit urinary diversion. (2011) (187)
- Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient Outcome (2004) (185)
- A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. (2002) (183)
- Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. (2011) (182)
- Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. (2011) (182)
- Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. (2000) (179)
- Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. (1996) (171)
- Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? (2005) (167)
- Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. (2002) (166)
- The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. (2004) (165)
- Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. (2003) (163)
- 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target (2005) (163)
- Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. (2010) (160)
- Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. (2002) (160)
- Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness (2005) (158)
- Percutaneous renal cryoablation: experience treating 115 tumors. (2008) (158)
- Complications of contemporary open nephron sparing surgery: a single institution experience. (2005) (155)
- The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. (2005) (151)
- Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. (2010) (151)
- Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. (1999) (150)
- Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. (2005) (150)
- Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. (2004) (149)
- Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma (2005) (146)
- Pathologic staging of renal cell carcinoma (2001) (141)
- Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. (1999) (140)
- Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. (2002) (139)
- Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. (1992) (137)
- Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. (2002) (137)
- A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. (2003) (132)
- Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. (2011) (130)
- Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. (2002) (130)
- The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. (2010) (127)
- Lymph node dissection in renal cell carcinoma. (2011) (126)
- Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. (2009) (123)
- The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses (2009) (123)
- Transvesical peritoneoscopy: initial clinical evaluation of the bladder as a portal for natural orifice translumenal endoscopic surgery. (2007) (123)
- Renal nephrometry score is associated with urine leak after partial nephrectomy (2011) (122)
- Preoperative nomogram predicting 12-year probability of metastatic renal cancer. (2008) (121)
- Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer (2007) (120)
- Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. (2005) (117)
- Analysis of the RNASEL gene in familial and sporadic prostate cancer. (2002) (117)
- Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study (2006) (117)
- Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. (2006) (116)
- Ureteroscopy: effect of technology and technique on clinical practice. (2003) (116)
- Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy (2005) (115)
- Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. (2007) (115)
- Metastatic prostate carcinoma to bone (2002) (115)
- Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? (2005) (113)
- Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? (2005) (110)
- Outcomes following partial nephrectomy by tumor size. (2008) (106)
- Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy (2002) (105)
- The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. (2007) (105)
- Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma (2007) (104)
- Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen (2001) (102)
- Renal cell carcinoma: vena caval involvement (2007) (101)
- Costimulatory B 7-H 1 in renal cell carcinoma patients : Indicator of tumor aggressiveness and potential therapeutic target (2004) (101)
- Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. (2004) (100)
- High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma (2006) (99)
- Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. (2007) (98)
- Role of HPC2/ELAC2 in hereditary prostate cancer. (2001) (97)
- The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. (2000) (96)
- Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. (2002) (96)
- Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. (2004) (94)
- Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. (2002) (94)
- Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. (2001) (93)
- Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. (2000) (92)
- Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. (2005) (91)
- Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. (2007) (90)
- Pathologic classification of prostate carcinoma (1998) (90)
- Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. (2008) (89)
- Differences in organ system of distant metastasis by renal cell carcinoma subtype. (2008) (89)
- Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. (2003) (88)
- Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome (1999) (88)
- Perineural Invasion and MIB-1 Positivity in Addition to Gleason Score Are Significant Preoperative Predictors of Progression After Radical Retropubic Prostatectomy for Prostate Cancer (2002) (87)
- Surgery Insight: management of renal cell carcinoma with associated inferior vena cava thrombus (2008) (87)
- Development and evaluation of BioScore (2009) (87)
- Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up (2006) (87)
- Radiation therapy after radical prostatectomy: impact on metastasis and survival. (2009) (83)
- Treatment of patients with small renal masses: a survey of the American Urological Association. (2011) (82)
- Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. (2008) (81)
- Reassessing the diagnostic yield of saturation biopsy of the prostate. (2008) (80)
- Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. (2007) (79)
- Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. (2015) (78)
- TWO POSITIVE NODES REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER. A NEW PROPOSAL BASED ON A TWO INSTITUTION EXPERIENCE ON 784 CONSECUTIVE N+ PATIENTS (2008) (74)
- The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma (2006) (73)
- Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival (2006) (72)
- Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases (2009) (72)
- Percutaneous renal cryoablation: local control at mean 26 months of followup. (2010) (72)
- Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. (2001) (71)
- Metabolic and cardiovascular effects of androgen deprivation therapy (2008) (71)
- No association of germline alteration of MSR1 with prostate cancer risk (2003) (70)
- Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. (2006) (68)
- Nitrofurantoin: the return of an old friend in the wake of growing resistance (2008) (68)
- Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. (2008) (68)
- Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. (1997) (66)
- Functional and oncological outcomes after orthotopic neobladder reconstruction in women (2008) (65)
- Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base. (2014) (65)
- Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. (2008) (65)
- Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy (2003) (64)
- Erectile dysfunction and testosterone deficiency. (2009) (63)
- Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. (2007) (63)
- Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. (2006) (61)
- pT2 classification for renal cell carcinoma. Can its accuracy be improved? (2005) (59)
- Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. (2017) (58)
- Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. (2010) (58)
- Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion (2007) (58)
- The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. (2008) (57)
- Surgical management of renal cell carcinoma. (2006) (57)
- Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. (2003) (57)
- Metastatic potential of a renal mass according to original tumour size at presentation (2012) (57)
- Genome linkage screen for prostate cancer susceptibility loci: Results from the Mayo Clinic familial prostate cancer study (2003) (56)
- B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. (2005) (56)
- Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. (2005) (54)
- The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. (2009) (54)
- Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. (1999) (54)
- Multifactorial, site‐specific recurrence model after radical cystectomy for urothelial carcinoma (2010) (52)
- Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. (2005) (51)
- 668 A RANDOMIZED PHASE II STUDY OF IPILIMUMAB WITH ANDROGEN ABLATION COMPARED WITH ANDROGEN ABLATION ALONE IN PATIENTS WITH ADVANCED PROSTATE CANCER (2010) (50)
- Long‐term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate‐specific antigen level ≥50 ng/mL (2008) (50)
- Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma. (2003) (50)
- Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract (2008) (49)
- Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. (2009) (49)
- Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. (2007) (47)
- Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. (2006) (47)
- Imperative indications for conservative management of upper tract transitional cell carcinoma. (2007) (44)
- The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. (2006) (44)
- Surgery for renal cell carcinoma metastases (2010) (43)
- Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer (2011) (42)
- After radical retropubic prostatectomy ‘insignificant’ prostate cancer has a risk of progression similar to low‐risk ‘significant’ cancer (2007) (40)
- Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. (2006) (39)
- Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? (2011) (39)
- Preventing pain during office biopsy of the prostate (2007) (38)
- Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? (2004) (37)
- Clinical research priorities in Renal cell carcinoma (1997) (37)
- Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. (2008) (37)
- Impact of prostate‐specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers (2008) (35)
- Update on pathologic staging of renal cell carcinoma. (2002) (35)
- Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001 (2006) (35)
- Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol (2009) (35)
- Primary Retroperitoneal Lipoma: A Soft Tissue Pathology Heresy?: Report of a Case With Classic Histologic, Cytogenetics, and Molecular Genetic Features (2008) (33)
- Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies (2018) (32)
- pT1 clear cell renal cell carcinoma (2002) (32)
- At what point does warm ischemia cause permanent renal damage during partial nephrectomy? (2007) (31)
- Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. (2007) (30)
- Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. (2006) (30)
- Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. (2015) (30)
- Percutaneous biopsy for risk stratification of renal masses (2015) (29)
- Tumor-Infiltrating Foxp 3 CD 4 + CD 25 + TCells Predict Poor Survival in Renal Cell Carcinoma (2007) (28)
- Critical comparison of laparoscopic, robotic, and open radical prostatectomy: Techniques, outcomes, and cost (2006) (28)
- Long‐term outcome of multiple ipsilateral renal tumours found at the time of planned nephron‐sparing surgery (2008) (28)
- Tissue ablation technologies for localized prostate cancer. (2004) (28)
- Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. (2007) (28)
- Surgery for vena caval tumor extension in renal cancer (2009) (28)
- Prognostic value of p53 and MIB‐1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement (2004) (27)
- The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. (2002) (27)
- Platinum-Chemotherapy for Advanced Transitional Cell Carcinoma of the Upper Urinary Tract (1996) (27)
- Radical retropubic prostatectomy in immunosuppressed transplant recipients. (2008) (27)
- Unclassified renal cell carcinoma: impact on survival following nephrectomy. (2010) (26)
- Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer (2014) (26)
- Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma (2008) (26)
- Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? (2007) (26)
- Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. (2006) (25)
- How long is too long? The effect of the duration of anaesthesia on the incidence of non‐urological complications after surgery (2008) (25)
- Lymph node dissection in the management of renal cell carcinoma. (2008) (25)
- Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series (2005) (25)
- The kidney in the tuberous sclerosis complex. (1994) (25)
- Radical prostatectomy by open or laparoscopic/robotic techniques: an issue of surgical device or surgical expertise? (2008) (24)
- Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. (2016) (24)
- Prostate specific antigen kinetics in the management of prostate cancer. (2008) (24)
- DNA ploidy and surgically treated prostate cancer. Important independent association with prognosis for patients with prostate carcinoma treated by radical prostatectomy (1995) (24)
- Loss of Igf2 Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth. (2017) (24)
- Pharmacoangiographic evidence of the presence and anatomical dominance of accessory pudendal artery(s). (2008) (24)
- Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. (2005) (24)
- Addressing the need for repeat prostate biopsy: new technology and approaches (2015) (23)
- The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications (2015) (23)
- Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. (2006) (23)
- Pathologic T1 clear cell renal cell carcinoma: Insulin‐like growth factor‐I receptor expression and disease‐specific survival (2004) (23)
- Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy (2017) (23)
- Second primary malignancies associated with renal cell carcinoma histological subtypes. (2006) (22)
- Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. (2006) (21)
- Predictors of cancer progression in T1a prostate adenocarcinoma (1999) (21)
- The management of superficial transitional cell carcinoma of the bladder. (2006) (20)
- Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. (2005) (20)
- 1. Redefining pT3 renal cell carcinoma in the modern era: A proposal for a revision of the current TNM primary tumor classification system (2008) (19)
- Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma (2012) (19)
- Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus (2017) (19)
- Multifocal Renal Cell Carcinoma: Clinicopathologic Features and Outcomes for Tumors ≤4 cm (2008) (19)
- Flutamide in Men with Prostatic Intraepithelial Neoplasia: A Randomized, Placebo-Controlled Chemoprevention Trial (2006) (18)
- Surgical management of high risk prostate cancer: the Mayo Clinic experience. (2008) (18)
- Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. (2010) (17)
- Wegener's granulomatosis presenting as renal mass: a case for nephron-sparing surgery. (2005) (16)
- Management of the Incidental Adrenal Mass. (2016) (16)
- Radical prostatectomy: does surgical technique influence margin control? (2010) (16)
- Critical comparison of laparoscopic, robotic, and open radical prostatectomy: techniques, outcomes, and cost (2006) (15)
- Wegener's granulomatosis presenting as multiple bilateral renal masses. (2004) (15)
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer. (2015) (15)
- Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis (2019) (15)
- Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years (2019) (15)
- Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy. (2010) (14)
- Surgery for metastatic renal cell cancer (2005) (14)
- Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. 1996. (2002) (14)
- Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumors: Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA, Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX (2008) (14)
- Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation (2006) (14)
- Coffee grounds emesis: rare presentation of testicular cancer treated with neoadjuvant chemotherapy. (2004) (13)
- Delayed Intervention of Small Renal Masses on Active Surveillance (2017) (13)
- The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma (2002) (13)
- The use of urine-based biomarkers in bladder cancer. (2006) (13)
- Molecular Targets for Radiation Oncology in Prostate Cancer (2011) (13)
- Radical prostatectomy for prostate cancer after ileal pouch-anal anastomosis offers oncologic control and sustains quality of life. (2010) (13)
- Simple graphic method for estimation of prostate-specific antigen doubling time. (2006) (13)
- Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbits (2006) (12)
- Do percutaneous renal tumor biopsies at initial presentation affect treatment strategies? (2009) (12)
- Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma. (2007) (12)
- Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less. (2003) (12)
- The effect of Gleason score on the predictive value of prostate‐specific antigen doubling time (2009) (12)
- Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression (2017) (11)
- Open partial nephrectomy for tumor in a solitary kidney: Experience with 400 cases (2006) (11)
- PREOPERATIVE NOMOGRAM TO PREDICT POSITIVE LYMPH NODES DURING NEPHRECTOMY FOR RENAL CELL CARCINOMA (2008) (10)
- Case 5-2017. A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass. (2017) (10)
- Continent Orthotopic Urinary Diversion in Female Patients: Early Mayo Clinic Experience (1999) (10)
- MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER. (2019) (10)
- 513: Renal Preservation During Ischemia Utilizing a Retrograde Approach and a Perfluorocarbon Emulsion Demonstrated in the Rabbit Model (2005) (9)
- A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer (2017) (9)
- Metachronous renal tumours after surgical management of oncocytoma (2011) (9)
- Tumor Cell andTumorVasculature Expression of B 7-H 3 Predict Survival in Clear Cell Renal Cell Carcinoma (2008) (9)
- Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy. (2013) (9)
- Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing (2020) (9)
- Editorial comment on: Renal angiomyolipoma: long-term results following selective arterial embolization. (2009) (9)
- Role of HPC 2 / ELAC 2 in Hereditary Prostate Cancer 1 (2001) (8)
- Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. (2006) (8)
- Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma. (2015) (8)
- Potential underdetection of pT(3a) renal-cell carcinoma with laparoscopic morcellation. (2007) (8)
- Predictors and oncological outcomes following positive surgical margins at partial nephrectomy (2009) (8)
- Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence. (2020) (8)
- Positive surgical margins after radical prostatectomy: does it matter? (2014) (8)
- Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis (2020) (7)
- No proof of inferiority: open radical retropubic prostatectomy remains state-of-the-art surgical technique for localized prostate cancer. (2009) (7)
- 1022: Early Complications and Surgical Margin Status Following Radical Retropubic Prostatectomy (RRP) Compared to Robot-Assisted Laparoscopic Prostatectomy (RALP) (2005) (7)
- Expression of Immunosuppresive B 7-H 3 Ligandby Hormone-Treated Prostate Cancer Tumors andMetastases (2009) (7)
- Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy. (2021) (7)
- Radical prostatectomy for high-risk prostate cancer. (2010) (7)
- Prognostic significance of indeterminate lung nodules in renal cell carcinoma. (2014) (6)
- Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. (2006) (6)
- Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric Analysis. (2017) (6)
- Dynamic prediction of metastases after radical prostatectomy for prostate cancer (2011) (6)
- Down-staging of locally advanced prostate cancer with anti-CTLA-4 monoclonal antibody prior to radical prostatectomy. (2009) (5)
- Can radiotherapy be a viable salvage treatment option for the relapsed seminoma confined to the infra-diaphragm region recurring after primary chemotherapy for bulky stage II seminoma? (2013) (5)
- 1073 RADICAL NEPHRECTOMY FOR BENIGN RENAL MASSES IS ASSOCIATED WITH DIMINISHED OVERALL SURVIVAL COMPARED WITH PARTIAL NEPHRECTOMY (2011) (5)
- 641: Is Partial Nephrectomy for Small Renal Masses Associated with Improved Overall Survival Compared with Radical Nephrectomy? (2007) (5)
- Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level (2020) (5)
- DEVELOPMENT AND INTERNAL VALIDATION OF THE FIRST NOMOGRAM PREDICTING LONG-TERM PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2008) (5)
- Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer (2016) (5)
- Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma (2009) (5)
- LONG-TERM SURVIVAL AFTER RADICAL PROSTATECTOMY FOR PATIENTS WITH HIGH RISK PROSTATE CANCER IN THE PSA ERA (2008) (4)
- 723: Long Term Outcome after Radical Prostatectomy for Patients with Lymph Node Positive Prostate Cancer in the PSA ERA (2007) (4)
- Re: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood. J Urol 2007; 178: 1878-1882. (2008) (4)
- Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. (2010) (4)
- The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer (2006) (4)
- 710: High Expression Levels of Survivin Protein are an Independent Predictor of Poor Outcome Among Patients Treated Surgically for Clear Cell Renal Cell Carcinoma (2006) (4)
- The role of lymphadenectomy in the management of renal cell carcinoma (2014) (4)
- Surgical management of renal cell carcinoma invading the vena cava (2002) (4)
- 22: Cardiopulmonary Bypass with Circulatory Arrest Versus Veno-Venous Bypass in Patients Undergoing Venous Thrombectomy: Comparison of Mortality and Morbidity (2004) (4)
- VALIDATION OF THE PARTIN TABLES FOR PREDICTING PATHOLOGIC STAGE OF CLINICALLY CONFINED PROSTATE CANCER (1999) (4)
- Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progress. (2004) (3)
- EVIDENCE FOR BENEFIT OF ADJUVANT RADIATION THERAPY IN LOCALIZED PROSTATE CANCER WITH POSITIVE SURGICAL MARGIN AT THE PROSTATE BASE (1999) (3)
- Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy. (2011) (3)
- Imaging , Diagnosis , Prognosis Identification of a Soluble Form of B 7-H 1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (3)
- Letters to the Editor/Errata RE: NEPHRON SPARING SURGERY FOR APPROPRIATELY SELECTED RENAL CELL CARCINOMA BETWEEN 4 AND 7 CM RESULTS IN OUTCOME SIMILAR TO RADICAL NEPHRECTOMY (2004) (3)
- The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. (2004) (3)
- Re: The accuracy of 250 fine needle biopsies of renal tumors. (2005) (3)
- 1784: Association of Paraneoplastic Syndromes with Outcome Following Radical Nephrectomy for Clear Cell Renal Cell Carcinoma (2004) (3)
- THE IMPACT OF POSITIVE SURGICAL MARGINS ON MORTALITY FOLLOWING RADICAL PROSTATECTOMY (2009) (3)
- LONG-TERM OUTCOME AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH NORMAL CONTRALATERAL KIDNEY (1999) (3)
- 1782: Robotic-Assisted Laparoscopic Partial Nephrectomy (2004) (3)
- A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery. (2016) (3)
- Use and timing of radiotherapy in high-risk prostate cancer. (2004) (3)
- SIGNIFICANCE OF THE 1997 TNM STAGING SYSTEM FOR PATHOLOGIC CLASSIFICATION OF RENAL CELL CARCINOMA (1999) (3)
- Nephron-sparing surgery: the 'gold standard' treatment for small renal cortical tumors (2007) (3)
- Conference on Evaluation and Managment of Benign prostatic Hyperplasia, Cambridge, Massachusets, March 31 2001: Introduction (2001) (3)
- The evolving role of renal mass biopsy. (2016) (3)
- MP50-05 SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH THE REPURPOSED DRUG METFORMIN (2016) (3)
- Prognostic and predictive biomarkers for metastatic renal cell carcinoma (2021) (2)
- PROSPECTIVE ANALYSIS OF NEEDLE BIOPSY OF SOLID RENAL MASSES (1999) (2)
- Surgical Treatment of 4-10 cm Renal-Cell Carcinoma: A Survey of the Lions and Gazelles. (2017) (2)
- A prospective randomized EORTC intergroup Phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma (2008) (2)
- 601: Timing of Androgen Deprivation Therapy and Its Impact on Cancer-Specific Survival after Radical Prostatectomy: A Matched-Cohort Analysis (2007) (2)
- 1065 TO BIOPSY OR NOT TO BIOPSY: RESULTS OF 1000 RENAL MASS BIOPSIES AT A SINGLE INSTITUTION (2013) (2)
- MP55-11 SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH METFORMIN (2015) (2)
- The impact of family history on pathological and clinical outcomes in non‐syndromic clear cell renal cell carcinoma (2010) (2)
- Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma: Buchner A, Riesenberg R, Kotter I, Hofstetter A, Stief C, Oberneder R, Department of Urology, Klinikum Groshadern, Ludwig-Maximilians-University, Munich, Germany (2006) (2)
- ONCOLOGIC OUTCOMES FOR PATIENTS WITH POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY (2008) (2)
- MP44-16 PREDICTORS OF NON-DIAGNOSTIC RENAL MASS BIOPSY (2015) (2)
- Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. (2021) (2)
- Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma (2008) (2)
- STAGING OF T1 VERSUS T2 RENAL CELL CARCINOMA: THE ISSUE OF TUMOR SIZE CUTPOINT (1999) (2)
- Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy (2020) (2)
- 742: Features Predictive of Local Recurrence Following Nephron-Sparing Surgery for Renal Caell Carcinoma (2006) (2)
- 1777: Differences in Site of Distant Metastases by Renal Cell Carcinoma Subtype (2004) (2)
- 10 YEAR SURVIVAL AFTER RADICAL NEPHRECTOMY AND TUMOR THROMBECTOMY FOR RENAL CELL CARCINOMA WITH RENAL VEIN OR VENA CAVA TUMOR THROMBUS (1999) (2)
- Refining the early detection and staging of prostate cancer. (1995) (2)
- 845: Gleason Score 6 Prostate Cancer Involving ≤5% of the Needle Biopsy Does Not Predict Biochemical Progression, Final Pathologic Stage, Grade, or Margin Status in Radical Prostatectomy Specimen (2004) (1)
- Peri-operative comparison between daVinci-assisted radical prostatectomy and open radical prostatectomy in obese patients (2007) (1)
- OUTCOMES IN PATIENTS WITH ADVANCED STAGE RENAL CELL CARCINOMA TREATED WITH NEPHRON SPARING SURGERY (2009) (1)
- RADICAL PROSTATECTOMY FOR PROSTATIC ADENOCARCINOMA: MATCHED COMPARISON OF RETROPUBIC AND ROBOT ASSISTED TECHNIQUES (2008) (1)
- Cell Carcinoma Patients with Long-term Follow-up Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal (2006) (1)
- Re: Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the Search database. (2004) (1)
- A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy (2001) (1)
- 1268: Accuracy of Predicting Eventual PSA Doubling Time Using Early Detectable PSA Results (2004) (1)
- COMPARISON OF URINARY CYTOLOGY, BTA stat, NMP22, FDP, TELOMERASE, CHEMILUMINESCENT HEMOGLOBIN AND THE HEMOGLOBIN DIPSTICK IN THE DETECTION OF BLADDER CANCER (1999) (1)
- Lack of referral bias in genetic studies of prostate cancer. (2002) (1)
- Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm (2006) (1)
- 746: Mononuclear Cell Infiltration in Clear Cell Renal Cell Carcinoma Independently Predicts Patient Survival (2006) (1)
- Prognostic significance of indeterminate lung nodules in renal cell carcinoma. (2013) (1)
- Concordance of systematic and fusion biopsy with surgical pathology. (2019) (1)
- 2046 BIOPSY KI-67 IS A STRONG PREDICTOR OF SYSTEMIC PROGRESSION AND CANCER-SPECIFIC DEATH FOLLOWING RADICAL PROSTATECTOMY (2010) (1)
- METASTASECTOMY FOR PATIENTS WITH MULTIPLE METASTASES OF RENAL CELL CARCINOMA: A COMPARISON OF COMPLETE VERSE INCOMPLETE RESECTION (2009) (1)
- Comment on: Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy. Authors' reply (2008) (1)
- 1423: The Impact of Gleason Score on the Predictive Value of PSA Doubling Time (2007) (1)
- Using aorta lesion attenuation difference (ALAD) on preoperative contrast-enhanced CT scan to differentiate between malignant and benign renal tumors. (2018) (1)
- Morbidity after brachytherapy for prostate adenocarcinoma [1] (multiple letters) (2004) (1)
- SURVIVAL FOLLOWING PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM (2009) (1)
- Editorial: Refining Early Detection and Staging of Prostate Cancer (1995) (1)
- IDENTIFICATION OF POTENTIAL SERUM MARKERS IN CLEAR CELL RENAL CELL CARCINOMA (2008) (1)
- 1. Microvascular tumor invasion in renal cell carcinoma: The most important prognostic factor (2008) (1)
- 1146: Margin Positivity in Patients Diagnosed Pathologically with Small Organ-Confined Prostatic Adenocarcinomas: Trends in the PSA Era (2007) (1)
- PREDICTION OF BIOCHEMICAL FAILURES AFTER RADICAL PROSTATECTOMY FOR SPECIMEN-CONFINED PROSTATE CANCER (1999) (1)
- Active surveillance of renal masses in elderly patients: Abouassaly R, Lane BR, Novick AC, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH (2009) (1)
- Comment on: The accuracy of 250 fine needle biopsies of renal tumors (2005) (1)
- CLINICAL T1c AND T2 PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY: OUTCOME ACCORDING TO PRE-OPERATIVE PSA AND CLINICAL GRADE IN THE PSA ERA (1999) (1)
- POD-03.07: High tumor expression of KI-67 is an independent predictor of poor outcome among patients treated surgicaly for clear cell renal cell carcinoma (2007) (1)
- 1765: An Outcome Prediction Model for Cancer-Specific Survival Following Metastatic Clear Cell Renal Cell Carcinoma (2004) (1)
- 950: Pre-Operative PSA Doubling Time is More Powerful than PSA or PSA Velocity as a Predictor of Post Radical Prostatectomy Outcomes (2005) (1)
- IMMUNOHISTOCHEMICAL BIOMARKERS VERSUS CLINICAL AND PATHOLOGIC FEATURES IN THE PREDICTION OF SURVIVAL FOR PATIENTS WITH METASTATIC RENAL CELL (2009) (1)
- 1127: Association of Preoperative Elevated Erythrocyte Sedimentation Rate and Anemia with Survival Following Radical Nephrectomy for Chromophobe, Papillary, and Clear Cell Renal Cell Carcionoma (2006) (1)
- 1403: “Insignificant” Prostate Cancer Treated by Radical Retropubic Prostatectomy has a Risk of Progression Similar to Low-Risk “Significant” Cancer (2007) (1)
- Re: Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology. (2004) (1)
- The impact of histological variants on bladder cancer survival: A population-based analysis. (2016) (1)
- Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience (2008) (1)
- 1028: Percutaneous Image Guided Cryotherapy is a Minimally Invasive Option for Select Renal Tumors (2006) (1)
- Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer. (2014) (1)
- The Role for Radical Prostatectomy in Advanced Prostate Cancer (2012) (1)
- SURGICAL RESECTION OF ISOLATED RETROPERITONEAL LYMPH NODE RECURRENCE OF RENAL CELL CARCINOMA (2008) (1)
- 1115: The Impact of Lymphadenectomy at the Time of Nephrectomy for Metastatic RCC (2006) (1)
- Evaluation of the timing of adjuvant mitomycin C following nephroureterectomy for urothelial carcinoma of the upper urinary tract. (2018) (1)
- Diagnostic value of CT urography in the evaluation of gross hematuria (2001) (1)
- DO RESULTS OF RADICAL PROSTATECTOMY FOR PSA DETECTED CANCERS (T1c) SUPPORT PSA SCREENING (1999) (1)
- 46 ADJUVANT RADIOTHERAPY HAS A POSITIVE IMPACT ON CANCER-SPECIFIC SURVIVAL OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS OF A TWO-INSTITUTION SERIES WITH 703 LYMPH NODE POSITIVE PATIENTS (2009) (1)
- 826: Radical Prostatectomy for Clinically Advanced (CT3) Prostate Cancer in the PSA Era: 15-Year Outcomes (2005) (1)
- POSTOPERATIVE SURVEILLANCE MODEL FOLLOWING CYSTECTOMY FOR CLINICALLY LOCALIZED UROTHELIAL CARCINOMA OF THE BLADDER (2009) (0)
- MP26-08 RENIN-ANGIOTENSIN INHIBITORS DECREASE RECURRENCE AFTER TURBT IN NON-MUSCLE INVASIVE BLADDER CANCER (2015) (0)
- MP61-05 GENETIC MUTATIONS AS PROGNOSTIC BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA (2021) (0)
- 1652: Independent Validation of the 2003 AJCC Tumor Staging System Using a Large Single-Institution Cohort of Patients Treated with Radical Nephrectomy (2004) (0)
- 304 DOES BMI “DILUTE” THE PREDICTIVE PROPERTY OF PSA FOR TUMOR VOLUME AT RADICAL PROSTATECTOMY? (2010) (0)
- 73: Preoperative and Intraoperative Features Associated with Positive Lymph Nodes During Nephrectomy for Renal Cell Carcinoma (2006) (0)
- 1779: Cancer-Specific Survival in Patients with PT2 Renal Cell Carcinoma: is the Current Tumor Classification Accurate? (2004) (0)
- 1957: Assessing Local Anesthesia for Prostate Biopsy in the Office Setting: A Randomized, Prospective Clinical Trial (2007) (0)
- Editorial comment. (2009) (0)
- Considerations: Imaging in Renal Cell Carcinoma (2009) (0)
- IMPACT OF DISCORDANCE BETWEEN CLINICAL AND PATHOLOGICAL GLEASON SCORE ON SURVIVAL FOLLOWING RADICAL PROSTATECTOMY (2008) (0)
- TESTICULAR CANCER (2019) (0)
- COMPARING COMPLICATIONS AND SURVIVAL OF PRIMARY CYSTECTOMY VS. SALAVAGE CYSTECTOMY AFTER TRIMODAL THERAPY: PD36‐12 (2017) (0)
- 960: Preoperative Prediction of Pathologic Features and Outcome in Patients with Clinically Confined Solid Renal Tumors (2005) (0)
- LONG-TERM OUTCOME OF MULTIPLE IPSILATERAL RENAL TUMORS FOUND AT TIME OF PLANNED NEPHRON SPARING SURGERY (2008) (0)
- Morbidity After Brachytherapy for Prostate Adenocarcinoma: In Response (2004) (0)
- 630 LIPID-POOR LESIONS OF TUBEROUS SCLEROSIS; A ROLE FOR PERCUTANEOUS BIOPSY (2013) (0)
- 793: The Impact of Surgical Margin Positivity at the Time of Prostatectomy on Cancer-Specific Survival in the Post-PSA ERA (2004) (0)
- 728: Dynamic Assessment of Systemic Progression Risk after Radical Retropubic Prostatectomy (2007) (0)
- 1121: The Relationship between Renal Angiomyolipoma, Renal Cell Carcinoma and Tuberous Sclerosis (2006) (0)
- MP83-11 LONG-TERM PATIENT-REPORTED FUNCTIONAL OUTCOMES FOLLOWING OPEN, LAPAROSCOPIC, AND ROBOTIC-ASSISTED RADICAL PROSTATECTOMY PERFORMED BY HIGH VOLUME SURGEONS (2015) (0)
- MP49-17 CLINICAL OUTCOMES OF PATIENTS WITH HISTOLOGIC VARIANTS OF BLADDER CANCER TREATED WITH TRIMODAL BLADDER-SPARING THERAPY (2016) (0)
- Both Fleischner Society and the American College of Chest Physicians guidelines for the management of incidentally (2014) (0)
- MP59-04 OPTIMAL TREATMENT FOR 4-10CM RENAL CELL CARCINOMA: A SURVEY OF ENDOUROLOGISTS AND UROLOGIC ONCOLOGISTS (2015) (0)
- 268: Trends in Gleason Grading of Radical Retropubic Prostatectomy Specimens over Time (2005) (0)
- 387: The Immunomodulatory Protein B7-H4 Expression in Renal Cell Carcinoma Patients: A Strong Predictor of Cancer Progression and Survival (2006) (0)
- MP26-09 MODERATE CHRONIC KIDNEY DISEASE (EGFR < 60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION (2015) (0)
- 733: Cancer-Specific Mortality is Increased by Erythrocyte Transfusion in Patients Undergoing Surgery for Renal Cell Carcinoma (2006) (0)
- COMPARING PREDICTIVE ACCURACY FOR FOUR PROGNOSTIC MODELS OF RECURRENCE FOLLOWING SURGERY IN NON‐METASTATIC RENAL CELL CARCINOMA WITH THROMBUS USING CONTEMPORARY DATA FROM SIX INSTITUTIONS: MP55‐13 (2017) (0)
- 425 NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL NEPHROURETERECTOMY IN PATIENTS WITH ADVANCED UPPER TRACT UROTHELIAL CARCINOMA (2010) (0)
- COMBINED EXPRESSION OF B7-H1 AND PD-1 AMONG PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2009) (0)
- Clinical correlates of renal angiomyolipoma subtypes in 209 patients: Classic, fat poor, tuberous sclerosis associated, and epithelioid (2009) (0)
- 87: Dynamic Outcome Prediction in Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy (2006) (0)
- Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma (2005) (0)
- Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013 (2021) (0)
- 271: Age at Treatment is not a Good Predictor of Outcome Following Radical Retropubic Prostatectomy (2005) (0)
- 507: Patients with PT1 Renal Cell Carcinoma who Die from Disease after Nephrectomy may have Unrecognized Renal Sinus Fat Invasion (2007) (0)
- Pathologic quiz case: a 56-year-old man with bilateral renal masses. Bilateral renal oncocytosis. (2004) (0)
- The Clinical Significance of the Positive Surgical Margin and Dominant Tumor Laterality Following Radical Prostatectomy: A Retrospective Study (2022) (0)
- Caveat emptor. (2014) (0)
- PD41-02 NOMOGRAM TO PREDICT RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS USING A MULTI-CENTER CONTEMPORARY SERIES (2016) (0)
- MP50-09 ROLE OF REPEAT BIOPSY IN THE FOLLOW-UP OF RENAL LESIONS WITH A PRIOR NON-DIAGNOSTIC BIOPSY OF THE SAME MASS (2015) (0)
- 1100: Endoscopic Management of Upper Tract Urothelial Carcinoma in Patient with a History of Primary Bladder Urothelial Carcinoma (2006) (0)
- Platinum Priority – Prostate Cancer (2011) (0)
- Management of Renal Adenomas and Oncocytomas (2008) (0)
- 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION (2010) (0)
- MP62-12 CONDITIONAL FREEDOM FROM PROGRESSION ON ACTIVE SURVEILLANCE OF PROSTATE CANCER STRATIFIED BY NCCN RISK (2021) (0)
- 1385: Stratification of Patient Risk Based on PSA Doubling Time Following Radical Retropubic Prostatectomy (2006) (0)
- 448: Tumor Vasculature Expression of B7-H3 in Renal Cell Carcinoma (2007) (0)
- 1771: Radical Retropubic Prostatectomy in Immunosuppressed Transplant Patients (2007) (0)
- 1604: Cancer-Specific Mortality is Increased by Erythrocyte Transfusion in Patients Undergoing Radical Retropubic Prostatectomy (2006) (0)
- PD52-03 GENETIC MUTATIONS AS PREDICTIVE BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA (2021) (0)
- 1098: Potential Underdetection of PT3A Renal Cell Carcinoma with Laparoscopic Morcellation (2006) (0)
- 1. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer: Li G, Feng G, Gentil-Perret A, Genin C, Tostain J, Department of Urology, North Hospital, CHU of Saint-Etienne, Saint-Etienne, France (2009) (0)
- 766 Robotic assisted laparoscopic partial nephrectomy (2004) (0)
- 1250: Pre-Surgical Nomogram Predicting 12-Year Probability of Metastatic Recurrence Following Nephrectomy for Renal Masses (2007) (0)
- 1026: Radiofrequency Ablation of Renal Mass in Solitary Kidneys (2006) (0)
- Abstract A45: The association between type 2 diabetes mellitus and incidence of renal cell carcinoma (RCC) and fatal RCC in two prospective cohorts (2015) (0)
- COMPETING RISK ANALYSIS AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (<or= to T2) ACCORDING TO CLINICAL GLEASON SCORE AND AGE (1999) (0)
- 830: PSA Doubling Time is an Important Predictor of Outcome in Patients with Hormone Refractory Recurrence following Prostatectomy (2005) (0)
- LONG-TERM COMPLICATIONS OF INCONTINENT CONDUIT URINARY DIVERSIONS (2009) (0)
- Urothelial Cell Carcinoma of the Upper Urinary Tract: Introduction (2009) (0)
- The association between obesity and incidence of total and fatal renal cell carcinoma in two prospective cohorts. (2015) (0)
- 886 LONG-TERM SURVIVAL AFTER SURGERY VERSUS EXTERNAL BEAM RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER (2011) (0)
- Morbid obesity is not associated with worse outcomes following surgery for renal cell cancer (RCC) (2015) (0)
- 861: Serum Human Glandular Kallikrein 2 and Pro-Human Glandular Kallikrein 2 Concentration Correlates with Survival in Patients with Hormone Refractory Prostate Cancer (2006) (0)
- Clinical significance of renin-angiotensin system inhibition on non-muscle invasive bladder cancer (2015) (0)
- IMPACT OF FAMILY HISTORY ON OUTCOME IN RENAL CELL CARCINOMA (2008) (0)
- Conclusions: A surprisingly high number of resected angiomyolipomas was not suspected radiographically, indicating the importance of precise radiographic characterization to minimize nephrectomy for fat poor angiomyolipoma, which should remain a research priority. In this sizeable single institution (2009) (0)
- Chemoprevention of prostate cancer (2003) (0)
- 143: Is the GPSM Scoring Algorithm for Prostate Cancer Patients Valid in the Contemporary ERA? (2006) (0)
- 1948: Saturation Biopsy: Does it Really Detect More Cancer? (2007) (0)
- Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer (2016) (0)
- Morbidity after brachytherapy for prostate adenocarcinoma. Authors' replies (2004) (0)
- 288 THE EFFECT OF REGIONAL ANESTHESIA AND ANALGESIA DURING PROSTATECTOMY ON ONCOLOGIC OUTCOMES FOR PROSTATE CANCER (2010) (0)
- Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis (2022) (0)
- 965: Erythrocyte Sedimentation Rate: An Independent Prognostic Feature of Clear Cell Renal Cell Cancer (2005) (0)
- 1470 PROGRESSION TO MUSCLE INVASION DURING SURVEILLANCE OF UROTHELIAL CARCINOMA IS ASSOCIATED WITH POOR PROGNOSIS (2010) (0)
- COINHIBITORY MOLECULE EXPRESSION AND LYMPHOCYTIC INFILTRATION IN NON-CLEAR CELL RENAL CELL CARCINOMA (2008) (0)
- LONG-TERM FOLLOW-UP AFTER RADICAL PROSTATECTOMY FOR PATHOLOGICAL GLEASON >or= to 8 PROSTATE CANCER: INFLUENCE OF CONCOMITANT PATHOLOGICAL VARIABLES (1999) (0)
- 674 CLINICOPATHOLOGIC CORRELATION AND BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOR INTERMEDIATE RISK PROSTATE CANCER: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2013) (0)
- 471: Effect of a Family History of Prostate Cancer on Outcome After Radical Retropubic Prostatectomy (2004) (0)
- MP50-08 DIAGNOSTIC SUCCESS AND PREDICTION OF TUMOR SUBTYPE OF RENAL MASS BIOPSY IMPROVES WITH EXPERIENCE: LONGITUDINAL RESULTS IN A SINGLE SERIES COHORT OF 1233 TUMORS (2015) (0)
- 1907: The Role of Inferior Vena Caval Interruption During Radical Nephrectomy and Tumor Thrombectomy (2007) (0)
- The impact of a positive family history on clinical and pathologic outcomes of active surveillance for prostate cancer. (2021) (0)
- Abstract 109: DNA methylation profiling associated with recurrence of prostate cancer (2011) (0)
- 47: Endoscopic Treatment of Upper Tract Urothelial Carcinoma in Patients with Solitary Kidneys (2006) (0)
- 1803 PROGNOSIS IN PATIENTS WITH MULTIPLE METASTATIC LESIONS OF RENAL CELL CARCINOMA (2010) (0)
- Open Radical Prostatectomy: How Can Intra-Operative, Peri-Operative and Post-Operative Complications be Prevented? (2008) (0)
- 482: The Long-Term Impact of Obesity on Prostate Cancer After Radical Prostatectomy (2006) (0)
- Editorial Comment:: Prostate cancer screening: the case for patient-centered shared decision-making (2012) (0)
- 961: Scoring Algorithm to Predict Cancer-Specific Survival for Patients with Metastatic Renal Cell Carcinoma (2005) (0)
- SAFETY AND EFFICACY OF POST‐OPERATIVE EXTENDED‐DURATION VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH‐RISK UROLOGIC ONCOLOGY PATIENTS: MP92‐01 (2017) (0)
- 1683 DO PATIENTS WITH NORMAL RENAL FUNCTION TOLERATE LONGER PERIODS OF WARM ISCHEMIA DURING PARTIAL NEPHRECTOMY COMPARED WITH PATIENTS HARBORING CHRONIC KIDNEY DISEASE (2012) (0)
- Renal Cancer: Old and New Paradigms (2023) (0)
- Orthotopic urinary diversion in the female patient (2008) (0)
- Abstract 4950: Correlation of methylation status with expression levels of the genes in prostate cancer (2010) (0)
- 1090 EVALUATION OF MODIFIABLE AND NON-MODIFIABLE FEATURES ASSOCIATED WITH RENAL FUNCTION FOLLOWING PARTIAL NEPHRECTOMY (2011) (0)
- 386: Tumor B7-H1 is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long Term Follow-Up (2006) (0)
- 1214 CORRELATION OF PREOPERATIVE TESTOSTERONE LEVELS WITH BIOCHEMICAL FAILURE IN MEN UNDERGOING RADICAL PROSTATECTOMY (2010) (0)
- PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IS A MARKER OF SIGNIFICANT PROSTATE CANCER (1999) (0)
- 851: External Validation of Risk Group Analysis for Predicting PSA Recurrence Following Radical Prostatectomy and Comparison to the Mayo Clinic GPSM Score (2004) (0)
- 827 FACTORS ASSOCIATED WITH MANAGEMENT OF SMALL RENAL MASSES: A SURVEY OF THE AMERICAL UROLOGICAL ASSOCIATION (2010) (0)
- underutilized (reference 25 from paper). Hopefully, those who have been awaiting data from randomized trials before changing practice patterns will read these results and expand the application of nephron-sparing surgery. (2008) (0)
- Bilateral Renal Masses (2008) (0)
- 1249 PATHOLOGIC ANALYSIS AND ONCOLOGIC OUTCOMES OF RENAL MASSES IN HORSESHOE KIDNEYS (2010) (0)
- FUNCTIONAL AND ONCOLOGIC OUTCOMES AFTER ORTHOTOPIC URINARY DIVERSION IN WOMEN (2008) (0)
- MP35-09 MANAGEMENT OF SUSPICIOUS LIPID POOR RENAL MASSES IN THE TUBEROUS SCLEROSIS COMPLEX PATIENT WITH MULTIPLE RENAL LESIONS (2015) (0)
- 2064 Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy (1996) (0)
- Cardiopulmonary bypass with circulatory arrest versus veno-venous bypass in patients undergoing venous thrombectomy Comparison of mortality and morbidity (2004) (0)
- 107 : Comparison of Biochemical Failure Rates Between Permanent Prostate Brachytherapy and Radical Retropubic Prostatectomy Patients as a Function of Post-Therapy PSA Nadir Plus ‘X’ (2006) (0)
- ACTIVE SURVEILLANCE IS A VIABLE OPTION FOR MEN WITH BORDERLINE LOW‐RISK PROSTATE CANCER: PD55‐05 (2017) (0)
- 133 IMPACT OF ADJUVANT RADIOTHERAPY ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH SEMINAL VESICLE INVASION AND NODE POSITIVE DISEASE: RESULTS OF A MATCHED-ANALYSIS (2010) (0)
- The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer. (2018) (0)
- THE VALUE OF UPPER TRACT CYTOLOGY AFTER TRANSURETHRAL RESECTION OF BLADDER TUMOR IN PATIENTS WITH BLADDER TRANSITIONAL CELL CANCER: EDITORIAL COMMENT (1999) (0)
- Comment on: Renal vein or inferior vena caval extension in patients with renal cortical tumors: Impact of tumor histology. Authors' reply (2004) (0)
- MP13-12 MODERATE CHRONIC KIDNEY DISEASE (EGFR <60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION (2016) (0)
- DETERMINANTS OF QUALITY OF LIFE AMONG PROSTATE CANCER SURVIVORS TREATED BY COMMUNITY PRACTICES (2009) (0)
- MP48-19 NEED FOR INTERVENTION AND SURVIVAL IN A COHORT OF PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2019) (0)
- Lymph Node Dissection for Small Renal Masses. (2017) (0)
- EVALUATION OF PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM (2014) (0)
- 1463: Cancer Characteristics in Men Diagnosed with Prostate Cancer Subsequent to Initial Biopsy Showing High Grade Prostatic Intraepithelial Neoplasia (2005) (0)
- MP17-14 THE PROGNOSTIC IMPACT OF A NEGATIVE CONFIRMATORY BIOPSY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2018) (0)
- ACTIVE SURVEILLANCE FOR LOW‐RISK PROSTATE CANCER IN MEN UNDER 60 YEARS OF AGE: PD55‐03 (2017) (0)
- NITROFURANTOIN AS A FIRST-LINE AGENT IN UNCOMPLICATED UTIs (2008) (0)
- THE IMPACT OF THE PSA ERA ON THE INCIDENCE AND PREDICTORS OF POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY (2009) (0)
- The Progession Landscape of Diagnostic and Treatment Options for Kidney Cancer. (2023) (0)
- Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy (2020) (0)
- MP50-07 THE ASSOCIATION BETWEEN OBESITY AND INCIDENCE OF TOTAL AND FATAL RENAL CELL CARCINOMA IN TWO PROSPECTIVE COHORTS (2015) (0)
- Risk of bladder cancer following external beam radiation for prostate cancer (2004) (0)
- 104 Lack of referral bias in genetic studies of prostate cancer (2002) (0)
- MP-19.15: Urinary fluorescence in situ hybridization predicts long-term disease status after bacillus Calmette-Guerin therapy (2007) (0)
- ANALYSIS OF RISK FACTORS FOR PROGRESSION IN PATHOLOGICALLY CONFINED PROSTATE CANCERS RETROPUBIC PROSTATECTOMY (1996) (0)
- 1587: Primary Gleason Grade 4 Prostate Cancer Treated by Radical Prostatectomy: Pathological Stage, DNA Ploidy and Tumor Size are Stronger Determinants of Survival than Secondary Gleason Grade (2006) (0)
- PD35-05 MULTICENTER VALIDATION OF PREDICTIVE MODEL FOR POSTSURGICAL RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS (2015) (0)
- 620 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH SEMINAL VESICLE INVASION TREATED WITH RADICAL PROSTATECTOMY AND ADJUVANT RADIATION THERAPY. RESULTS FROM A TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- Conditional progression-free survival in men on active surveillance for prostate cancer stratified by NCCN risk. (2021) (0)
- Editorial comment. (2011) (0)
- 319: Survivin and B7-H1 are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal cell Carcinoma (2007) (0)
- Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin (2006) (0)
- INFLUENCE OF PERINEPHRIC FAT INVASION ON SURVIVAL, TUMOR RECURRENCE AND METASTASIS 10 YEARS AFTER RADICAL NEPHRECTOMY (1999) (0)
- 383: Rare Expression or Mutation of C-KIT in Grade 4 Renal Cell Carcinoma with or without Sarcomatoid Differentiation (2006) (0)
- Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer. (2023) (0)
- 646: 25-Year Outcomes of Radical Prostatectomy for the Treatment of All Stages of Non-Metastatic Prostate Cancer (2006) (0)
- MP37-20 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY INDUCES SENESCENCE IN RADICAL PROSTATECTOMY SPECIMENS (2015) (0)
- 399: Complete Tumor Regression of Established Murine Renal Cell Carcinoma Following CD4+ T Cell Depletion and B7-H1 Blockade (2006) (0)
- Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus. (2023) (0)
- Trends of Muscle Invasive Bladder Cancer: Evidence from the SEER Database, 1988 to 2013 (2020) (0)
- Immune cell marker expressed in kidney cancer and predicts aggressiveness (2004) (0)
- 1150: Impact of the PSA Era on Pathological and Clinical Outcomes after Radical Prostatectomy in Gleason 8-10 Cancers (2007) (0)
- 865 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH PT3B PCA TREATED WITH RP AND ADJUVANT RT. RESULTS FROM TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- 803: Updated Morbidity of Radical Retropubic Prostatectomy for Localized Prostate Cancer (2004) (0)
- A PROSPECTIVE REVIEW OF QUALITY OF LIFE OUTCOMES AFTER RADICAL RETROPUBIC PROSTATECTOMY: A PRELIMINARY REPORT (1999) (0)
- 1108: Surgical Management, Complications, and Outcome of Vascular Bypass for Renal Cell Carcinoma with Venous Tumor Thrombus (2007) (0)
- MP64-15 A CRITICAL ANALYSIS OF POSTOPERATIVE MORBIDITY IN MORBIDLY OBESE PATIENTS FOLLOWING RENAL CANCER SURGERY (2016) (0)
- 718: Influence of Activated T Cells on Bladder Cancer Progression (2004) (0)
- PD17-05 THE IMPACT OF A POSITIVE FAMILY HISTORY OF HEREDITARY CANCER-ASSOCIATED MALIGNANCIES ON OUTCOMES OF ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2021) (0)
- 1110: Cystic Clear Cell Renal Cell Carcinoma is Cured by Surgical Resection (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael L. Sr. Blute?
Michael L. Sr. Blute is affiliated with the following schools:
